0,864  0,004  Antineoplastic (non-small cell lung cancer)
0,821  0,004  Caspase 3 stimulant
0,813  0,007  Antineoplastic (lung cancer)
0,798  0,011  Caspase 9 stimulant
0,767  0,003  Cardiodepressant
0,765  0,021  Apoptosis agonist
0,683  0,014  15-Lipoxygenase inhibitor
0,671  0,008  Antineoplastic (melanoma)
0,668  0,025  Antineoplastic (breast cancer)
0,642  0,005  Antineoplastic (multiple myeloma)
0,622  0,008  Antineoplastic (brain cancer)
0,625  0,018  CYP2C9 substrate
0,625  0,021  Antileukemic
0,603  0,004  Anesthetic general
0,605  0,008  Antipyretic
0,602  0,013  CYP2D6 substrate
0,602  0,014  CYP1A2 substrate
0,582  0,006  Antineoplastic (glioblastoma multiforme)
0,579  0,016  Sensitization
0,570  0,010  Antineoplastic (glioma)
0,564  0,005  Tubulin antagonist
0,603  0,053  Antiinflammatory
0,567  0,022  Prostate cancer treatment
0,549  0,015  Antioxidant
0,553  0,027  Antineoplastic (colon cancer)
0,554  0,028  Antineoplastic (colorectal cancer)
0,536  0,013  Free radical scavenger
0,528  0,008  Antineoplastic (renal cancer)
0,534  0,022  5 Hydroxytryptamine release stimulant
0,528  0,020  Spasmolytic
0,518  0,010  Antineoplastic (lymphoma)
0,516  0,009  Sedative
0,522  0,019  CYP2C19 inhibitor
0,518  0,016  Lipoxygenase inhibitor
0,512  0,011  Vasodilator
0,511  0,011  CYP3A4 inhibitor
0,509  0,022  Radioprotector
0,489  0,005  Breast cancer-resistant protein inhibitor
0,506  0,027  Antiallergic
0,507  0,028  Respiratory analeptic
0,491  0,019  NOS2 expression inhibitor
0,479  0,013  Psychostimulant
0,473  0,010  Antineoplastic (small cell lung cancer)
0,470  0,010  Antineoplastic (carcinoma)
0,498  0,044  Transcription factor NF kappa B inhibitor
0,461  0,016  Antimitotic
0,462  0,017  UGT2B4 substrate
0,455  0,011  P-glycoprotein inhibitor
0,446  0,009  Genotoxic
0,465  0,032  Antineoplastic (ovarian cancer)
0,441  0,010  Hepatoprotectant
0,476  0,045  CYP3A4 substrate
0,451  0,023  Chemopreventive
0,433  0,012  Muscle relaxant
0,438  0,033  Hepatic disorders treatment
0,414  0,012  Antiseptic
0,413  0,010  Antineoplastic (squamous cell carcinoma)
0,416  0,020  Antihypertriglyceridemic
0,417  0,024  Nitric oxide antagonist
0,397  0,009  Skeletal muscle relaxant
0,404  0,030  Mutagenic
0,409  0,036  Antineoplastic (pancreatic cancer)
0,409  0,037  12-Lipoxygenase inhibitor
0,407  0,043  Antihypercholesterolemic
0,410  0,050  Angiogenesis inhibitor
0,364  0,015  Melanin inhibitor
0,412  0,069  Histamine release inhibitor
0,366  0,025  Antineoplastic (lymphocytic leukemia)
0,378  0,043  Vasodilator, coronary
0,346  0,011  Liver fibrosis treatment
0,361  0,028  Sigma receptor agonist
0,345  0,016  Anesthetic
0,346  0,020  Antimutagenic
0,327  0,004  Alpha tubulin antagonist
0,375  0,053  FMO1 substrate
0,364  0,047  Analeptic
0,359  0,044  Antineoplastic (cervical cancer)
0,349  0,034  Antineoplastic (liver cancer)
0,393  0,080  TNF expression inhibitor
0,349  0,038  Carcinogenic
0,345  0,044  CYP1A2 inhibitor
0,315  0,014  Neurotrophic factor enhancer
0,318  0,022  Skin irritative effect
0,301  0,005  UGT2B10 substrate
0,301  0,019  Lipid peroxidase inhibitor
0,296  0,014  Acetylcholinesterase inhibitor
0,293  0,011  Carcinogenic, group 1
0,300  0,026  VCAM1 expression inhibitor
0,294  0,021  Skin whitener
0,315  0,050  Antiprotozoal (Leishmania)
0,268  0,004  Papain-like protease (SARS coronavirus) inhibitor
0,275  0,011  Carcinogenic, group 2B
0,278  0,015  Anesthetic local
0,311  0,049  Tumour necrosis factor alpha release inhibitor
0,259  0,008  Cyclooxygenase 3 inhibitor
0,284  0,038  Abortion inducer
0,318  0,074  Apoptosis antagonist
0,336  0,093  GST A substrate
0,313  0,074  AR expression inhibitor
0,293  0,055  Hypoglycemic
0,273  0,036  Proto-oncogene tyrosine-protein kinase Fyn inhibitor
0,360  0,126  Transcription factor inhibitor
0,236  0,006  Carcinogenic, group 2A
0,294  0,066  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,295  0,069  CYP2C19 substrate
0,285  0,060  GST M1-1 substrate
0,274  0,050  5 Hydroxytryptamine 1E antagonist
0,280  0,057  5 Hydroxytryptamine uptake stimulant
0,248  0,027  UGT2B15 substrate
0,233  0,013  Microtubule formation inhibitor
0,278  0,067  DNA damaging
0,242  0,031  Cholinergic
0,349  0,140  Antineoplastic (solid tumors)
0,282  0,075  Hypoxia-inducible factor 1 alpha inhibitor
0,207  0,006  CDC-like kinase 3 inhibitor
0,247  0,048  UGT1A1 substrate
0,308  0,110  CYP2C9 inhibitor
0,281  0,082  CYP2D6 inhibitor
0,216  0,023  Topoisomerase I inhibitor
0,262  0,068  Proliferative diseases treatment
0,212  0,021  Alpha 2b adrenoreceptor antagonist
0,255  0,065  Hypolipemic
0,219  0,029  Topoisomerase II inhibitor
0,225  0,035  LDLR expression enhancer
0,254  0,065  Cytostatic
0,206  0,020  Butyrylcholinesterase inhibitor
0,232  0,047  CYP2B6 inhibitor
0,187  0,007  Prostaglandin EP2 antagonist
0,186  0,009  Beta tubulin antagonist
0,180  0,004  Potassium channel Kv1.3 blocker
0,200  0,024  5-Lipoxygenase inhibitor
0,193  0,019  Choleretic
0,259  0,085  Lipoprotein disorders treatment
0,279  0,106  Antineoplastic (endocrine cancer)
0,293  0,121  GABA C receptor rho-3 antagonist
0,225  0,054  Pneumotoxic
0,291  0,121  Immunosuppressant
0,185  0,016  Vanilloid 1 agonist
0,172  0,004  Endothelin receptor antagonist
0,212  0,045  UGT1A3 substrate
0,171  0,007  Phosphodiesterase XI inhibitor
0,171  0,007  Phosphodiesterase 11A inhibitor
0,168  0,009  UGT2B11 substrate
0,227  0,071  Antiulcerative
0,180  0,026  Adenylate cyclase stimulant
0,198  0,045  Amylase inhibitor
0,251  0,098  Antihypoxic
0,176  0,023  Alpha 2c adrenoreceptor antagonist
0,191  0,038  Cyclooxygenase 1 inhibitor
0,305  0,157  Alpha-glucosidase inhibitor
0,161  0,014  CYP2A6 inhibitor
0,160  0,014  Transcription factor NF kappa B stimulant
0,158  0,013  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,167  0,023  Antineoplastic alkaloid
0,262  0,119  Vasodilator, peripheral
0,162  0,021  Topoisomerase II alpha inhibitor
0,201  0,061  5 Hydroxytryptamine 3E antagonist
0,257  0,119  ICAM1 expression inhibitor
0,185  0,048  UGT2B9 substrate
0,203  0,068  Non-steroidal antiinflammatory agent
0,152  0,020  DOPA decarboxylase inhibitor
0,254  0,123  Antithrombotic
0,167  0,037  MAO A inhibitor
0,216  0,086  Antihypotensive
0,220  0,091  Cardiovascular analeptic
0,167  0,039  Protein-tyrosine phosphatase 1B inhibitor
0,191  0,064  Male reproductive disfunction treatment
0,190  0,062  UGT1A4 substrate
0,271  0,145  Antiprotozoal
0,153  0,028  HDL-cholesterol increasing
0,186  0,062  Succinate dehydrogenase inhibitor
0,156  0,034  GST P1-1 substrate
0,237  0,115  FMO3 substrate
0,174  0,052  CDC-like kinase 1 inhibitor
0,139  0,019  Inducible nitric-oxide synthase inhibitor
0,176  0,056  Uterine stimulant
0,177  0,058  Protein-tyrosine phosphatase inhibitor
0,131  0,015  Phosphodiesterase V inhibitor
0,157  0,041  Antitussive
0,164  0,049  Antifungal enhancer
0,129  0,015  Vanilloid agonist
0,163  0,049  Carcinogenic, group 3
0,182  0,069  UGT2B7 substrate
0,194  0,081  Amyloid beta aggregation inhibitor
0,175  0,064  ATPase inhibitor
0,114  0,005  Exportin-1 inhibitor
0,154  0,045  Monophenol monooxygenase inhibitor
0,125  0,017  Phosphodiesterase 5A inhibitor
0,153  0,046  Epidermal growth factor receptor kinase inhibitor
0,190  0,083  Insulin sensitizer
0,202  0,096  RNA-directed DNA polymerase inhibitor
0,244  0,138  Thioredoxin glutathione reductase inhibitor
0,133  0,028  Calcium antagonist
0,191  0,086  Pyruvate kinase inhibitor
0,143  0,038  Alcohol dehydrogenase substrate
0,173  0,069  Phobic disorders treatment
0,109  0,004  Endothelin A receptor antagonist
0,108  0,004  Endothelin B receptor antagonist
0,246  0,143  Antiprotozoal (Plasmodium)
0,145  0,044  Interleukin 1b antagonist
0,127  0,025  Phosphodiesterase 4D inhibitor
0,161  0,060  GABA C receptor rho-2 antagonist
0,130  0,029  Phosphodiesterase IV inhibitor
0,113  0,014  Prokinetic
0,116  0,018  Leukotriene synthesis inhibitor
0,129  0,033  Alpha 2 adrenoreceptor antagonist
0,130  0,036  Electron transport complex I inhibitor
0,146  0,055  Heat shock protein 70 antagonist
0,140  0,050  Antiprotozoal (Amoeba)
0,125  0,035  Antiviral (SARS coronavirus)
0,125  0,035  Antiviral (Coronavirus)
0,150  0,060  MAO inhibitor
0,149  0,060  Neurotrophic factor
0,116  0,027  Alpha 2d adrenoreceptor antagonist
0,202  0,115  Superoxide dismutase inhibitor
0,227  0,142  Cholesterol antagonist
0,111  0,027  ATPase (Vacuolar H+) inhibitor
0,152  0,069  Cyclooxygenase inhibitor
0,098  0,016  Endocannabinoid uptake inhibitor
0,104  0,024  GABA aminotransferase inhibitor
0,119  0,039  Nitric-oxide synthase inhibitor
0,090  0,013  Leukotriene B4 antagonist
0,105  0,027  Glutamate decarboxylase inhibitor
0,205  0,128  Chemoprotective
0,083  0,006  Factor III inhibitor
0,153  0,077  Eye irritation, high
0,204  0,128  Tyrosine 3 hydroxylase inhibitor
0,095  0,019  Antitreponemal
0,124  0,048  Expectorant
0,178  0,104  Antiparasitic
0,082  0,008  Ryanodine receptor antagonist
0,124  0,051  Mucolytic
0,080  0,008  Adenylate cyclase 1 inhibitor
0,202  0,130  Cardioprotectant
0,146  0,075  Acaricide
0,166  0,095  Cytotoxic
0,112  0,042  Estrogen receptor beta antagonist
0,115  0,045  Sphingomyelinase inhibitor
0,104  0,035  Tocolytic
0,181  0,113  UGT1A6 substrate
0,082  0,015  Peristaltic stimulant
0,122  0,060  Antifungal (Pneumocystis)
0,210  0,150  Prostaglandin dehydrogenase inhibitor
0,184  0,126  Vascular (periferal) disease treatment
0,166  0,108  Embryotoxic
0,117  0,061  Estrogen antagonist
0,066  0,010  Squalene synthetase inhibitor
0,129  0,073  Phosphodiesterase inhibitor
0,126  0,073  Cyclooxygenase 2 inhibitor
0,163  0,114  Teratogen
0,086  0,037  Lipase inhibitor
0,054  0,006  Leukotriene B4 receptor 1 antagonist
0,137  0,089  Antiviral (Herpes)
0,065  0,018  Anesthetic inhalation
0,189  0,145  Antineoplastic (sarcoma)
0,053  0,009  Melatonin agonist
0,085  0,042  Estrogen receptor alpha antagonist
0,069  0,027  Postmenopausal disorders treatment
0,053  0,011  Vesicle monoamine transporter inhibitor
0,075  0,034  Glutamate (mGluR7) antagonist
0,163  0,122  Antiparkinsonian, rigidity relieving
0,104  0,064  Antifungal (Aspergillus)
0,115  0,076  Antiviral (Hepatitis B)
0,079  0,040  Calcium channel L-type blocker
0,069  0,032  Alpha 2 adrenoreceptor agonist
0,100  0,063  Sulfotransferase substrate
0,146  0,110  Platelet adhesion inhibitor
0,111  0,076  Shock treatment
0,150  0,114  Antineoplastic (bone cancer)
0,131  0,096  Heat shock protein 90 antagonist
0,046  0,011  Melatonin 1 agonist
0,091  0,059  Antiviral (Hepatitis A)
0,095  0,063  Phosphodiesterase 6D inhibitor
0,070  0,039  Beta adrenoreceptor antagonist
0,077  0,047  Phosphodiesterase VI inhibitor
0,121  0,092  Protein kinase stimulant
0,172  0,144  Peptidyltransferase inhibitor
0,062  0,035  Fibroblast growth factor 4 antagonist
0,074  0,047  Histidine decarboxylase inhibitor
0,042  0,014  Melatonin 2 agonist
0,068  0,042  Leukotriene antagonist
0,134  0,108  Arachidonic acid antagonist
0,039  0,015  Melatonin receptor 1A agonist
0,182  0,159  Radiosensitizer
0,077  0,053  Narcotic antagonist
0,131  0,108  Interferon gamma antagonist
0,030  0,007  Imidazoline I1 receptor antagonist
0,043  0,020  Diamine oxidase inhibitor
0,181  0,159  UGT1A9 substrate
0,068  0,047  Alpha adrenoreceptor agonist
0,177  0,157  DNA synthesis inhibitor
0,099  0,079  GST T1-1 substrate
0,112  0,093  NADPH oxidase inhibitor
0,083  0,064  Ornithine decarboxylase inhibitor
0,081  0,064  Epidermal growth factor antagonist
0,074  0,057  Nicotinic alpha4beta2 receptor antagonist
0,101  0,085  TRPA1 agonist
0,154  0,139  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,139  0,124  Antihelmintic
0,091  0,077  Anabolic
0,123  0,109  NOS3 expression enhancer
0,091  0,077  GABA C receptor rho-1 antagonist
0,073  0,060  GABA B receptor agonist
0,043  0,032  Dihydrofolate reductase inhibitor
0,056  0,044  Aromatase inhibitor
0,055  0,044  Postcoital contraceptive
0,093  0,082  UGT2B1 substrate
0,061  0,052  Beta 3 adrenoreceptor antagonist
0,061  0,052  5 Hydroxytryptamine 1A antagonist
0,092  0,083  Antiprotozoal (Toxoplasma)
0,015  0,008  Melatonin receptor 1A antagonist
0,045  0,037  Phosphodiesterase 6C inhibitor
0,056  0,051  5 Hydroxytryptamine 2A agonist
0,022  0,018  Dopamine autoreceptor agonist
0,137  0,134  Phospholipase C inhibitor
0,056  0,054  Dopamine D1 antagonist

